hotspot -WSS

hotspot

author：leisure time 2025-10-02 21:06:58 - browse：1386

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： CMS got Medicare Advantage quality rating wrong, judge rules

knowledge

WSS

Infectious disease expert Jeanne Marrazzo assumes Fauci role

FDA approves Moderna’s RSV vaccine, its second licensed product

Micronoma's microbiome cancer diagnostic approach under fire

What to expect as Trump is arraigned on his Jan 6. indictment

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Finland to offer bird flu vaccine to select groups of people, a possible global first

knowledge

hotspot

Wikipedia

At least 13 dead in Texas as scorching temps continue

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Cancer drug shortages should be causing more outrage

Illumina board agrees to spin off Grail, as divestment plans proceed

Medicare details structure of new drug price negotiation program

UnitedHealth CEO's Medicaid comments send insurer stocks diving

New air purifier tech could be key to improving indoor air quality

STAT wants to know your pick for a great summer read or listen

hotspot

Scientists inch closer to single

How CO2 helps viruses stay alive longer in the air

Eli Lilly’s Zepbound improved liver scarring in mid

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

What the US credit downgrade means for the economy, your finances

Fight over Supreme Court dialysis ruling puts kidney patients at risk

knowledge

knowledge

leisure time

hotspot